144 related articles for article (PubMed ID: 36379227)
21. Peripheral stem cell transplantation in a child with amegakaryocytic thrombocytopenia.
Yeşilipek ; Hazar V; Küpesiz A; Yegin O
Bone Marrow Transplant; 2000 Sep; 26(5):571-2. PubMed ID: 11019849
[TBL] [Abstract][Full Text] [Related]
22. Reduced intensity hematopoietic stem-cell transplantation across human leukocyte antigen barriers in a patient with congenital amegakaryocytic thrombocytopenia and monosomy 7.
Steele M; Hitzler J; Doyle JJ; Germeshausen M; Fernandez CV; Yuille K; Dror Y
Pediatr Blood Cancer; 2005 Aug; 45(2):212-6. PubMed ID: 15782403
[TBL] [Abstract][Full Text] [Related]
23. c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia.
Ballmaier M; Germeshausen M; Schulze H; Cherkaoui K; Lang S; Gaudig A; Krukemeier S; Eilers M; Strauss G; Welte K
Blood; 2001 Jan; 97(1):139-46. PubMed ID: 11133753
[TBL] [Abstract][Full Text] [Related]
24. Reduced intensity transplantation for congenital amegakaryocytic thrombocytopenia: report of a case and review of the literature.
Woods G; Bajwa RP; Rose MJ
Pediatr Transplant; 2014 Feb; 18(1):E31-4. PubMed ID: 24119002
[TBL] [Abstract][Full Text] [Related]
25. Congenital amegakaryocytic thrombocytopenic purpura (CAMT).
Ghauri RI; Naveed M; Mannan J
J Coll Physicians Surg Pak; 2014 Apr; 24(4):285-7. PubMed ID: 24709246
[TBL] [Abstract][Full Text] [Related]
26. Congenital amegakaryocytic thrombocytopenia with multiple physical anomalies in a female neonate.
Saqlain N; Ahmed N; Qamar U
J Coll Physicians Surg Pak; 2014 Nov; 24 Suppl 3():S253-5. PubMed ID: 25518793
[TBL] [Abstract][Full Text] [Related]
27. Congenital amegakaryocytic thrombocytopenia: clinical presentation, diagnosis, and treatment.
Ballmaier M; Germeshausen M
Semin Thromb Hemost; 2011 Sep; 37(6):673-81. PubMed ID: 22102270
[TBL] [Abstract][Full Text] [Related]
28. Implications of mutations in hematopoietic growth factor receptor genes in congenital cytopenias.
Germeshausen M; Ballmaier M; Welte K
Ann N Y Acad Sci; 2001 Jun; 938():305-20; discussion 320-1. PubMed ID: 11458519
[TBL] [Abstract][Full Text] [Related]
29. Congenital amegakaryocytic thrombocytopenia (CAMT) presenting as severe pancytopenia in the first month of life.
Stoddart MT; Connor P; Germeshausen M; Ballmaier M; Steward CG
Pediatr Blood Cancer; 2013 Sep; 60(9):E94-6. PubMed ID: 23625800
[TBL] [Abstract][Full Text] [Related]
30. Congenital amegakaryocytic thrombocytopenia and thrombocytopenia with absent radii.
Geddis AE
Hematol Oncol Clin North Am; 2009 Apr; 23(2):321-31. PubMed ID: 19327586
[TBL] [Abstract][Full Text] [Related]
31. Case Report: Clinical Variation in Children With Thrombopoietin Receptor (C-MPL) Mutations: Report of 2 Cases.
Lo C; Alvarez E; Ohgami RS; Jeng M
J Pediatr Hematol Oncol; 2018 Jan; 40(1):67-70. PubMed ID: 28859041
[TBL] [Abstract][Full Text] [Related]
32. Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim.
Pecci A; Ragab I; Bozzi V; De Rocco D; Barozzi S; Giangregorio T; Ali H; Melazzini F; Sallam M; Alfano C; Pastore A; Balduini CL; Savoia A
EMBO Mol Med; 2018 Jan; 10(1):63-75. PubMed ID: 29191945
[TBL] [Abstract][Full Text] [Related]
33. Congenital amegakaryocytic thrombocytopenia: a case report of pediatric twins undergoing matched unrelated bone marrow transplantation.
Rao AA; Gourde JA; Marri P; Galardy PJ; Khan SP; Rodriguez V
J Pediatr Hematol Oncol; 2015 May; 37(4):304-6. PubMed ID: 25171451
[TBL] [Abstract][Full Text] [Related]
34. Functional analysis of single amino-acid mutations in the thrombopoietin-receptor Mpl underlying congenital amegakaryocytic thrombocytopenia.
Tijssen MR; di Summa F; van den Oudenrijn S; Zwaginga JJ; van der Schoot CE; Voermans C; de Haas M
Br J Haematol; 2008 Jun; 141(6):808-13. PubMed ID: 18422784
[TBL] [Abstract][Full Text] [Related]
35. CAMT in a female with developmental delay, facial malformations and central nervous system anomalies.
Martinón-Torres N; Vázquez-Donsión M; Loidi L; Couselo JM
Pediatr Blood Cancer; 2011 Mar; 56(3):452-3. PubMed ID: 21225925
[TBL] [Abstract][Full Text] [Related]
36. Congenital amegakaryocytic thrombocytopenia-3 novel c-MPL mutations and their phenotypic correlations.
Steinberg O; Gilad G; Dgany O; Krasnov T; Zoldan M; Laor R; Kapelushnik J; Gabriel H; Churi C; Stein J; Yaniv I; Tamary H
J Pediatr Hematol Oncol; 2007 Dec; 29(12):822-5. PubMed ID: 18090929
[TBL] [Abstract][Full Text] [Related]
37. Defective binding of ETS1 and STAT4 due to a mutation in the promoter region of
Capaci V; Adam E; Bar-Joseph I; Faleschini M; Pecci A; Savoia A
Haematologica; 2023 May; 108(5):1385-1393. PubMed ID: 36226497
[TBL] [Abstract][Full Text] [Related]
38. Congenital amegakaryocytic thrombocytopenia in three siblings: molecular analysis of atypical clinical presentation.
Gandhi MJ; Pendergrass TW; Cummings CC; Ihara K; Blau CA; Drachman JG
Exp Hematol; 2005 Oct; 33(10):1215-21. PubMed ID: 16219544
[TBL] [Abstract][Full Text] [Related]
39. Thrombopoietin is essential for the maintenance of normal hematopoiesis in humans: development of aplastic anemia in patients with congenital amegakaryocytic thrombocytopenia.
Ballmaier M; Germeshausen M; Krukemeier S; Welte K
Ann N Y Acad Sci; 2003 May; 996():17-25. PubMed ID: 12799278
[TBL] [Abstract][Full Text] [Related]
40. Congenital amegakaryocytic thrombocytopenia (CAMT): a case report with review of literature.
Desai SR; Ranade SR
Indian J Pathol Microbiol; 2007 Jul; 50(3):659-60. PubMed ID: 17883175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
